Compare IQV & NTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | NTR |
|---|---|---|
| Founded | 1982 | 2017 |
| Country | United States | Canada |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6B | 34.2B |
| IPO Year | 2013 | 2018 |
| Metric | IQV | NTR |
|---|---|---|
| Price | $207.07 | $64.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 22 |
| Target Price | ★ $227.13 | $75.45 |
| AVG Volume (30 Days) | 1.5M | ★ 3.0M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.95% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 1.61 | N/A |
| Revenue | ★ $9,739,000,000.00 | N/A |
| Revenue This Year | $6.77 | $4.03 |
| Revenue Next Year | $5.89 | N/A |
| P/E Ratio | $128.19 | ★ $18.99 |
| Revenue Growth | ★ 41.60 | N/A |
| 52 Week Low | $154.50 | $53.03 |
| 52 Week High | $247.05 | $85.36 |
| Indicator | IQV | NTR |
|---|---|---|
| Relative Strength Index (RSI) | 73.43 | 49.23 |
| Support Level | $159.91 | $58.39 |
| Resistance Level | $209.48 | $73.31 |
| Average True Range (ATR) | 6.76 | 1.38 |
| MACD | 2.83 | 0.32 |
| Stochastic Oscillator | 97.29 | 66.21 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients—nitrogen, potash, and phosphate—although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.